Evidence map›Paper›PMID 25946112›Full record

ArticlePLoS pathogens2015

Sequential conformational changes in the morbillivirus attachment protein initiate the membrane fusion process.

Nadine Ader-Ebert, Mojtaba Khosravi, Michael Herren, Mislay Avila, Lisa Alves, Fanny Bringolf, Claes Örvell, Johannes P Langedijk, Andreas Zurbriggen, Richard K Plemper and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Structure and supramolecular organization of the canine distemper virus attachment glycoprotein.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Measles Resurgence and Drug Development.Current opinion in virology · 2020
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Nadine Ader-EbertDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health (DCR-VPH), Vetsuisse Faculty, University of Bern, Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Mojtaba KhosraviDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health (DCR-VPH), Vetsuisse Faculty, University of Bern, Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Michael HerrenDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health (DCR-VPH), Vetsuisse Faculty, University of Bern, Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Mislay AvilaDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health (DCR-VPH), Vetsuisse Faculty, University of Bern, Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Lisa AlvesDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health (DCR-VPH), Vetsuisse Faculty, University of Bern, Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Fanny BringolfDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health (DCR-VPH), Vetsuisse Faculty, University of Bern, Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Claes ÖrvellDivision of Laboratory Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Johannes P LangedijkJanssen Infectious Diseases and Vaccines, Leiden, Netherlands.
Andreas ZurbriggenDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health (DCR-VPH), Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Richard K PlemperInstitute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, United States of America.
Philippe PlattetDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health (DCR-VPH), Vetsuisse Faculty, University of Bern, Bern, Switzerland.
University of Bern · CHGeorgia State University · USJanssen (Netherlands) · NLKarolinska University Hospital · SE

Funding

Identification and Pre-Clinical Evaluation of Measles Virus InhibitorsR01AI071002 · NIAID · GEORGIA STATE UNIVERSITY · PI PLEMPER, RICHARD K. · 2006 to 2022
$6.6M
Cryo-Electron and Biochemical Anaysis of Native Paramyxovirus Fusion ComplexesR01AI083402 · NIAID · GEORGIA STATE UNIVERSITY · PI PLEMPER, RICHARD K. · 2011 to 2015
$1.7M
Cryo-Electron and Biochemical Analysis of Native Paramyxovirus Fusion ComplexesR56AI083402 · NIAID · EMORY UNIVERSITY · PI PLEMPER, RICHARD K. · 2010 to 2010
$380k
NIAID NIH HHS AI071002NIAID NIH HHS AI083402NIAID NIH HHS R01 AI071002NIAID NIH HHS R01 AI083402NIAID NIH HHS R56 AI083402
6 · The paper itself

Abstract

Despite large vaccination campaigns, measles virus (MeV) and canine distemper virus (CDV) cause major morbidity and mortality in humans and animals, respectively. The MeV and CDV cell entry system relies on two interacting envelope glycoproteins: the attachment protein (H), consisting of stalk and head domains, co-operates with the fusion protein (F) to mediate membrane fusion. However, how receptor-binding by the H-protein leads to F-triggering is not fully understood. Here, we report that an anti-CDV-H monoclonal antibody (mAb-1347), which targets the linear H-stalk segment 126-133, potently inhibits membrane fusion without interfering with H receptor-binding or F-interaction. Rather, mAb-1347 blocked the F-triggering function of H-proteins regardless of the presence or absence of the head domains. Remarkably, mAb-1347 binding to headless CDV H, as well as standard and engineered bioactive stalk-elongated CDV H-constructs treated with cells expressing the SLAM receptor, was enhanced. Despite proper cell surface expression, fusion promotion by most H-stalk mutants harboring alanine substitutions in the 126-138 "spacer" section was substantially impaired, consistent with deficient receptor-induced mAb-1347 binding enhancement. However, a previously reported F-triggering defective H-I98A variant still exhibited the receptor-induced "head-stalk" rearrangement. Collectively, our data spotlight a distinct mechanism for morbillivirus membrane fusion activation: prior to receptor contact, at least one of the morbillivirus H-head domains interacts with the membrane-distal "spacer" domain in the H-stalk, leaving the F-binding site located further membrane-proximal in the stalk fully accessible. This "head-to-spacer" interaction conformationally stabilizes H in an auto-repressed state, which enables intracellular H-stalk/F engagement while preventing the inherent H-stalk's bioactivity that may prematurely activate F. Receptor-contact disrupts the "head-to-spacer" interaction, which subsequently "unlocks" the stalk, allowing it to rearrange and trigger F. Overall, our study reveals essential mechanistic requirements governing the activation of the morbillivirus membrane fusion cascade and spotlights the H-stalk "spacer" microdomain as a possible drug target for antiviral therapy.

Indexed as

Models, MolecularVirus InternalizationAmino Acid SubstitutionAnimalsAntibodies, MonoclonalAntigens, CDCell Adhesion MoleculesChlorocebus aethiopsDistemper Virus, CanineDogsHEK293 CellsHumansMembrane FusionMorbillivirusMutationProtein ConformationAntibodies, MonoclonalAntigens, CDCell Adhesion MoleculesReceptors, Cell SurfaceRecombinant ProteinsSignaling Lymphocytic Activation Molecule Family Member 1Viral Proteins

Identifiers

PMID25946112
PMCPMC4422687
OpenAlexW236129873

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.